VIZITRAV

This brand name is authorized in Austria, Cyprus, Estonia, Spain, France, Croatia, Lithuania, Netherlands, Poland

Active ingredients

The drug VIZITRAV contains one active pharmaceutical ingredient (API):

1 Travoprost UNII WJ68R08KX9 - TRAVOPROST

Travoprost, a prostaglandin F2α analogue, is a highly selective full agonist which has a high affinity for the prostaglandin FP receptor, and reduces the intraocular pressure by increasing the outflow of aqueous humour via trabecular meshwork and uveoscleral pathways. Read about Travoprost

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01EE04	Travoprost	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EE Prostaglandin analogues
Discover more medicines within S01EE04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1799433, 1799444
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 81831
Country: FR	Base de données publique des médicaments	Identifier(s): 67138300
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-128588342
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1090702, 1090703
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 61093
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100335068